Literature DB >> 9281595

Pharmacological characterization of the murine and human orthologs of multidrug-resistance protein in transfected human embryonic kidney cells.

B D Stride1, C E Grant, D W Loe, D R Hipfner, S P Cole, R G Deeley.   

Abstract

Overexpression of the human multidrug-resistance protein (MRP) causes a form of multidrug resistance similar to that conferred by P-glycoprotein, although the two proteins are only distantly related. In contrast to P-glycoprotein, human MRP has also been shown to be a primary active transporter of a structurally diverse range of organic anionic conjugates, some of which may be physiological substrates. At present, the mechanism by which MRP transports these compounds and mediates multidrug resistance is not understood. With the objective of developing an animal model for studies on the normal functions of MRP and its ability to confer multidrug resistance in vivo, we recently cloned the murine ortholog of MRP (mrp). To assess the degree of functional conservation between mrp and MRP, we directly compared the drug cross-resistance profiles they confer when transfected into human embryonic kidney cells, as well as their ability to actively transport leukotriene C4, 17beta-Estradiol 17beta-(D-glucuronide), and vincristine; mrp and MRP conferred similar drug resistance profiles, with the exception that only MRP conferred resistance to the anthracyclines tested. Consistent with these findings, accumulation of [3H]vincristine and [3H]VP-16 was decreased, and efflux of [3H]vincristine was increased in both murine and human MRP-transfected cell populations, whereas only human MRP-transfected cells displayed decreased accumulation and increased efflux of [3H]daunorubicin. Membrane vesicles derived from both transfected cell populations transported leukotriene C4 in an ATP-dependent manner with comparable efficiency, although the efficiency of 17beta-estradiol 17beta-(D-glucuronide) transport was somewhat higher with MRP transfectants. ATP-dependent transport of vincristine was also observed with vesicles from mrp and MRP transfectants but only in the presence of glutathione. These studies reveal intrinsic differences between the murine and human MRP orthologs with respect to their ability to confer resistance to a major class of chemotherapeutic drugs.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9281595     DOI: 10.1124/mol.52.3.344

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  19 in total

Review 1.  Portrait of multifaceted transporter, the multidrug resistance-associated protein 1 (MRP1/ABCC1).

Authors:  Eva Bakos; László Homolya
Journal:  Pflugers Arch       Date:  2006-12-23       Impact factor: 3.657

2.  Loss of multidrug resistance-associated protein 1 potentiates chronic doxorubicin-induced cardiac dysfunction in mice.

Authors:  Wei Zhang; Jun Deng; Manjula Sunkara; Andrew J Morris; Chi Wang; Daret St Clair; Mary Vore
Journal:  J Pharmacol Exp Ther       Date:  2015-09-09       Impact factor: 4.030

3.  Cloning and characterization of the rat multidrug resistance-associated protein 1.

Authors:  Ziping Yang; Cheryl S W Li; Danny D Shen; Rodney J Y Ho
Journal:  AAPS PharmSci       Date:  2002

Review 4.  Effect of Liver Disease on Hepatic Transporter Expression and Function.

Authors:  Nilay Thakkar; Jason R Slizgi; Kim L R Brouwer
Journal:  J Pharm Sci       Date:  2017-04-30       Impact factor: 3.534

5.  Development and characterization of a recombinant Madin-Darby canine kidney cell line that expresses rat multidrug resistance-associated protein 1 (rMRP1).

Authors:  Ziping Yang; Micha Horn; Joanne Wang; Danny D Shen; Rodney J Y Ho
Journal:  AAPS PharmSci       Date:  2004-03-09

6.  Species difference in intestinal absorption mechanism of etoposide and digoxin between cynomolgus monkey and rat.

Authors:  T Nishimura; Y Kato; N Amano; M Ono; Y Kubo; Y Kimura; H Fujita; A Tsuji
Journal:  Pharm Res       Date:  2008-07-15       Impact factor: 4.200

7.  Characterization and analyses of multidrug resistance-associated protein 1 (MRP1/ABCC1) polymorphisms in Chinese population.

Authors:  Ji-Ye Yin; Qiong Huang; Youyun Yang; Jian-Ting Zhang; Mei-Zuo Zhong; Hong-Hao Zhou; Zhao-Qian Liu
Journal:  Pharmacogenet Genomics       Date:  2009-03       Impact factor: 2.089

8.  Selective induction of chemotherapy resistance of mammary tumors in a conditional mouse model for hereditary breast cancer.

Authors:  Sven Rottenberg; Anders O H Nygren; Marina Pajic; Fijs W B van Leeuwen; Ingrid van der Heijden; Koen van de Wetering; Xiaoling Liu; Karin E de Visser; Kenneth G Gilhuijs; Olaf van Tellingen; Jan P Schouten; Jos Jonkers; Piet Borst
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-11       Impact factor: 11.205

9.  Nrf2 Regulates the Sensitivity of Mouse Keratinocytes to Nitrogen Mustard via Multidrug Resistance-Associated Protein 1 (Mrp1).

Authors:  Ronald G Udasin; Xia Wen; Kristin M Bircsak; Lauren M Aleksunes; Michael P Shakarjian; Ah-Ng Tony Kong; Diane E Heck; Debra L Laskin; Jeffrey D Laskin
Journal:  Toxicol Sci       Date:  2015-10-09       Impact factor: 4.849

10.  Loss of Mrp1 Potentiates Doxorubicin-Induced Cytotoxicity in Neonatal Mouse Cardiomyocytes and Cardiac Fibroblasts.

Authors:  Wei Zhang; Daret St Clair; Allan Butterfield; Mary Vore
Journal:  Toxicol Sci       Date:  2016-01-27       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.